Post-COVID19 Condition: Clinical Trials

2 trials for Post-COVID19 Condition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Post-COVID19 Condition: new trials by email Literature Review of Post-COVID19 Condition trials Research Report on Post-COVID19 Condition

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Amantadine Therapy for Cognitive Impairment in Long COVID
Amantadine - Long COVID, Post-COVID19 Condition
Phase 2CompletedOhio State University642023-12-072026-01-27
Plasma Exchange Therapy for Post- COVID-19 Condition: A Pilot, Randomized Double-Blind Study
Plasma Exchange Procedure, Sham Plasma Exchange Procedure - Post-COVID19 Condition
Phase 2CompletedFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia502022-09-222023-06-07

Narrower conditions

Post-Acute COVID-19 Syndrome (2)  ·  COVID-19 (1)  ·  Mental Fatigue (1)

Broader conditions

Chronic Disease (2)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Disease Attributes (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  Post-Infectious Disorders (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)

Interventions

Amantadine (1)  ·  Plasmapheresis (1)

Sponsors

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1)  ·  Ohio State University (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

Andrew I Schamess, MD (1)

Results publications

PMID 39994269